(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MIKROGEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MIKROGEN

ST13

US500000079105966

Class

1, 5, 42

Filing

79105966

Registration

4235784

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

04/03/2026

Trademark type

Word

Nice classes

1, 5, 42

Filing date

06/27/2011

Registration date

11/06/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/22/2024

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Neuried, DE

Examiner

CRAWFORD, MARY

Law office

L20

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Mikrogen GmbH
Mikrogen GmbH

Representatives

Chalin A. Smith Smith Patent Consulting

Technical classification

Nice Classes

Class 1Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic agentsreagents and diagnostic preparations for scientific purposes; biochemical agents and preparationsreagentsfor scientific purposesin particular recombinantly produced proteins and peptides; chemical and biochemical reagents and genetic identity tests comprised of reagents for the identification of DNA by means of PCR technology and hybridization

Class 5

Diagnostic agentsfor medical and pharmaceutical purposesmedical diagnostic reagents and radioactive pharmaceutical preparations for in vivo diagnostic use; biochemical agents and preparations for pharmaceutical purposespharmaceuticals for use in diagnosing bacterial and viral infectious diseases and autoimmune diseases; diagnostic agents for medical purposesrecombinantly or synthetically produced antigens for medicalin particular diagnostic purposes; diagnostic agents for medical purposeslysates of microorganismsin particular preparations of components of microorganisms usable for diagnostic purposes; diagnostic agents for carrying out serologic tests for medical purposes; biochemical preparations for carrying out verification tests for medical purposesdiagnosis of bacterial and viral infectious diseases and autoimmune diseases ; diagnostic preparations for medical usediagnostic preparations for carrying out western blot tests for medical purposes; diagnostic preparations for medical usediagnostic preparations for carrying out enzyme immune tests for medical purposes; diagnostic reagents for serologic test of infections for medical purposes

Class 42

Services of a medicalbacteriological and biochemical laboratoryin particular chemical synthesis of oligonucleotides; scientific analysis regarding reagents and probes for the identification of DNA by means of PCR technology and hybridization; research and development services in the field of bacteriologycytologyantibody technologychemistryimmunology and gene expression systemsin particular regarding cloningexpression and purification of proteins and antigens for third parties; biochemical research and development for recombinant production of partially purified proteins of microorganisms

Publications

History of USPTO decisions and trademark events.

40 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/02/2026

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

03/22/2024

71AG

REGISTERED-SEC.71 ACCEPTED

03/22/2024

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

03/21/2024

PR71

POST REGISTRATION ACTION MAILED - SEC.71

11/15/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/07/2023

ES71

TEAS SECTION 71 RECEIVED

04/06/2023

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

11/06/2021

RNWL

INTERNATIONAL REGISTRATION RENEWED

07/16/2021

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

10/12/2018

71AG

REGISTERED-SEC.71 ACCEPTED

10/12/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/23/2018

ES71

TEAS SECTION 71 RECEIVED

08/08/2018

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

11/06/2017

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/08/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/17/2013

FIMP

FINAL DISPOSITION PROCESSED

05/17/2013

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/06/2013

R.PR

REGISTERED-PRINCIPAL REGISTER

11/06/2012

GPNX

NOTIFICATION PROCESSED BY IB

09/30/2012

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/21/2012

PUBO

PUBLISHED FOR OPPOSITION

08/21/2012

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/01/2012

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/01/2012

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/01/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/13/2012

ALIE

ASSIGNED TO LIE

07/12/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/22/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/01/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/31/2012

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/31/2012

RFNT

REFUSAL PROCESSED BY IB

01/09/2012

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/22/2011

RFRR

REFUSAL PROCESSED BY MPU

12/22/2011

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/21/2011

CNRT

NON-FINAL ACTION WRITTEN

12/20/2011

MAFR

APPLICATION FILING RECEIPT MAILED

12/20/2011

DOCK

ASSIGNED TO EXAMINER

12/16/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/16/2011

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/15/2011

Continuous trademark protection

Get notified about every new filing that threatens MIKROGEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.